vs
Side-by-side financial comparison of Sanara MedTech Inc. (SMTI) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.
Velocity Financial, Inc. is the larger business by last-quarter revenue ($51.6M vs $27.5M, roughly 1.9× Sanara MedTech Inc.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -5.9%, a 73.2% gap on every dollar of revenue. On growth, Velocity Financial, Inc. posted the faster year-over-year revenue change (32.8% vs 4.6%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $3.9M). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs 21.8%).
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.
SMTI vs VEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.5M | $51.6M |
| Net Profit | $-1.6M | $34.8M |
| Gross Margin | 93.2% | — |
| Operating Margin | 23.5% | 97.0% |
| Net Margin | -5.9% | 67.3% |
| Revenue YoY | 4.6% | 32.8% |
| Net Profit YoY | 5.3% | 67.0% |
| EPS (diluted) | $-0.32 | $0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $27.5M | $51.6M | ||
| Q3 25 | $26.3M | $49.1M | ||
| Q2 25 | $25.8M | $47.6M | ||
| Q1 25 | $23.4M | $37.5M | ||
| Q4 24 | $26.3M | $38.9M | ||
| Q3 24 | $21.7M | $35.1M | ||
| Q2 24 | $20.2M | $32.4M | ||
| Q1 24 | $18.5M | $29.5M |
| Q4 25 | $-1.6M | $34.8M | ||
| Q3 25 | $-30.4M | $25.4M | ||
| Q2 25 | $-2.0M | $26.0M | ||
| Q1 25 | $-3.5M | $18.9M | ||
| Q4 24 | $-1.7M | $20.8M | ||
| Q3 24 | $-2.9M | $15.8M | ||
| Q2 24 | $-3.5M | $14.8M | ||
| Q1 24 | $-1.8M | $17.3M |
| Q4 25 | 93.2% | — | ||
| Q3 25 | 92.9% | — | ||
| Q2 25 | 92.5% | — | ||
| Q1 25 | 92.2% | — | ||
| Q4 24 | 91.4% | — | ||
| Q3 24 | 90.8% | — | ||
| Q2 24 | 90.0% | — | ||
| Q1 24 | 89.8% | — |
| Q4 25 | 23.5% | 97.0% | ||
| Q3 25 | 11.2% | 72.1% | ||
| Q2 25 | -0.1% | 71.3% | ||
| Q1 25 | -8.9% | 71.7% | ||
| Q4 24 | 18.6% | 82.5% | ||
| Q3 24 | 3.6% | 60.6% | ||
| Q2 24 | -14.3% | 61.3% | ||
| Q1 24 | -8.3% | 78.8% |
| Q4 25 | -5.9% | 67.3% | ||
| Q3 25 | -115.5% | 51.7% | ||
| Q2 25 | -7.8% | 54.6% | ||
| Q1 25 | -15.1% | 50.4% | ||
| Q4 24 | -6.5% | 53.5% | ||
| Q3 24 | -13.2% | 45.1% | ||
| Q2 24 | -17.4% | 45.6% | ||
| Q1 24 | -9.5% | 58.5% |
| Q4 25 | $-0.32 | $0.90 | ||
| Q3 25 | $-3.40 | $0.65 | ||
| Q2 25 | $-0.23 | $0.69 | ||
| Q1 25 | $-0.41 | $0.51 | ||
| Q4 24 | $-0.18 | $0.56 | ||
| Q3 24 | $-0.34 | $0.44 | ||
| Q2 24 | $-0.41 | $0.42 | ||
| Q1 24 | $-0.21 | $0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $16.6M | $92.1M |
| Total DebtLower is stronger | $46.0M | — |
| Stockholders' EquityBook value | $5.9M | $672.5M |
| Total Assets | $72.9M | $7.4B |
| Debt / EquityLower = less leverage | 7.74× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.6M | $92.1M | ||
| Q3 25 | $14.9M | $99.0M | ||
| Q2 25 | $17.0M | $79.6M | ||
| Q1 25 | $20.7M | $51.7M | ||
| Q4 24 | $15.9M | $49.9M | ||
| Q3 24 | $16.3M | $44.1M | ||
| Q2 24 | $6.2M | $47.4M | ||
| Q1 24 | $2.8M | $34.8M |
| Q4 25 | $46.0M | — | ||
| Q3 25 | $45.1M | — | ||
| Q2 25 | $44.2M | — | ||
| Q1 25 | $43.4M | — | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $30.1M | — | ||
| Q2 24 | $14.4M | — | ||
| Q1 24 | $9.7M | — |
| Q4 25 | $5.9M | $672.5M | ||
| Q3 25 | $6.1M | $634.3M | ||
| Q2 25 | $35.4M | $597.9M | ||
| Q1 25 | $36.7M | $563.2M | ||
| Q4 24 | $39.4M | $516.9M | ||
| Q3 24 | $39.8M | $484.6M | ||
| Q2 24 | $41.7M | $471.3M | ||
| Q1 24 | $43.3M | $452.9M |
| Q4 25 | $72.9M | $7.4B | ||
| Q3 25 | $71.1M | $7.0B | ||
| Q2 25 | $98.8M | $6.5B | ||
| Q1 25 | $96.4M | $6.0B | ||
| Q4 24 | $88.1M | $5.5B | ||
| Q3 24 | $88.5M | $5.2B | ||
| Q2 24 | $73.4M | $4.9B | ||
| Q1 24 | $70.9M | $4.6B |
| Q4 25 | 7.74× | — | ||
| Q3 25 | 7.33× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.18× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.22× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.9M | $18.2M |
| Free Cash FlowOCF − Capex | $3.9M | $17.9M |
| FCF MarginFCF / Revenue | 14.0% | 34.6% |
| Capex IntensityCapex / Revenue | 0.3% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | $2.2M | $40.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.9M | $18.2M | ||
| Q3 25 | $2.2M | $11.5M | ||
| Q2 25 | $2.7M | $7.7M | ||
| Q1 25 | $-2.0M | $3.5M | ||
| Q4 24 | $932.0K | $37.8M | ||
| Q3 24 | $2.1M | $-17.6M | ||
| Q2 24 | $-1.4M | $11.5M | ||
| Q1 24 | $-1.6M | $10.6M |
| Q4 25 | $3.9M | $17.9M | ||
| Q3 25 | $1.1M | $11.4M | ||
| Q2 25 | $902.7K | $7.6M | ||
| Q1 25 | $-3.7M | $3.5M | ||
| Q4 24 | $859.9K | $37.5M | ||
| Q3 24 | $2.0M | $-17.6M | ||
| Q2 24 | $-1.5M | $11.4M | ||
| Q1 24 | $-1.7M | $10.5M |
| Q4 25 | 14.0% | 34.6% | ||
| Q3 25 | 4.2% | 23.2% | ||
| Q2 25 | 3.5% | 15.9% | ||
| Q1 25 | -15.9% | 9.2% | ||
| Q4 24 | 3.3% | 96.4% | ||
| Q3 24 | 9.4% | -50.3% | ||
| Q2 24 | -7.3% | 35.1% | ||
| Q1 24 | -9.0% | 35.8% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 4.0% | 0.1% | ||
| Q2 25 | 6.8% | 0.2% | ||
| Q1 25 | 7.4% | 0.2% | ||
| Q4 24 | 0.3% | 0.7% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.3% | 0.3% | ||
| Q1 24 | 0.4% | 0.1% |
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | — | -1.11× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
VEL
| Related Party | $19.3M | 37% |
| Nonrelated Party | $16.9M | 33% |
| Other | $15.4M | 30% |
